Finotonlimab with chemotherapy in recurrent or metastatic head and neck cancer: a randomized phase 3 trial

发表于 2026-7-28 11:59:22

期刊：Nature Medicine

文献作者：Yuankai Shi; Wei Guo; Wei Wang; Yunteng Wu; Meiyu Fang; Xiaoming Huang; Ping Han; Qingyuan Zhang; Pin Dong; Xiaohong Zhou; Hanwei Peng; Chunhong Hu; Xiaopin Chen; Shurong Zhang; Zhiwei Chang; Xiaojiang Li; Yuhai Ding; Song Qu; Shanghua Jing; Songnan Zhang; Lin Gui; Yan Sun; Lin Wang; Yanyan Liu; Hui Wu; Guoqing Li; Zhichao Fu; Jianhua Shi; Hao Jiang; Yuansong Bai; Jiuwei Cui; Yulong Zheng; Wei Cui; Xiaojing Jia; Limin Zhai; Qingqing Cai; Deming Xiong; Yunong Wu; Junning Cao; Rong Wu; Guangyuan Hu; Liang Peng; Liangzhi Xie; Wenlin Gai; Yan Wang; Yuehua Su

出版日期：2024-9-

DOI号：10.1038/s41591-024-03110-7

下载链接：https://www.nature.com/articles/s41591-024-03110-7.pdf

文献链接：https://doi.org/10.1038/s41591-024-03110-7

当前文献来源于 Springer Science and Business Media LLC。

备注信息：

[其他期刊] Finotonlimab with chemotherapy in recurrent or metastatic head and neck cancer: a randomized phase 3 trial

发表回复

同分类求助

最新回复

站点公告

今日热心研友

（热心研友QQ群）

[其他期刊] Finotonlimab with chemotherapy in recurrent or metastatic head and neck cancer: a randomized phase 3 trial 一键复制